[go: up one dir, main page]

MX2018008004A - Preparacion farmaceutica compactada. - Google Patents

Preparacion farmaceutica compactada.

Info

Publication number
MX2018008004A
MX2018008004A MX2018008004A MX2018008004A MX2018008004A MX 2018008004 A MX2018008004 A MX 2018008004A MX 2018008004 A MX2018008004 A MX 2018008004A MX 2018008004 A MX2018008004 A MX 2018008004A MX 2018008004 A MX2018008004 A MX 2018008004A
Authority
MX
Mexico
Prior art keywords
pharmaceutical preparation
polymer
reducing
unpleasant taste
masking effect
Prior art date
Application number
MX2018008004A
Other languages
English (en)
Other versions
MX383987B (es
Inventor
Onuki Yoichi
Osawa Ryoichi
Original Assignee
Ssp Co Ltd Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ssp Co Ltd Japan filed Critical Ssp Co Ltd Japan
Publication of MX2018008004A publication Critical patent/MX2018008004A/es
Publication of MX383987B publication Critical patent/MX383987B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Un objeto de la presente invención es proveer una preparación farmacéutica compactada que tiene un excelente efecto de enmascaramiento de reducir un sabor desagradable provocado por un fármaco ácido y es capaz de mantener establemente una buena sensación de ingestión sin reducir el efecto de enmascaramiento en el sabor desagradable con el tiempo; una preparación farmacéutica compactada de la presente invención que logra el objeto anterior se caracteriza por que contiene partículas revestidas obtenidas al aplicar una película de un polímero soluble en los intestinos a partículas de núcleo que contienen un fármaco ácido, un polímero soluble en jugo gástrico, un polímero insoluble en agua, y un polímero soluble en agua.
MX2018008004A 2015-12-28 2016-12-26 Preparación farmacéutica compactada. MX383987B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015255826 2015-12-28
PCT/JP2016/088659 WO2017115745A1 (ja) 2015-12-28 2016-12-26 圧縮成型製剤

Publications (2)

Publication Number Publication Date
MX2018008004A true MX2018008004A (es) 2019-03-28
MX383987B MX383987B (es) 2025-03-14

Family

ID=59225052

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018008004A MX383987B (es) 2015-12-28 2016-12-26 Preparación farmacéutica compactada.

Country Status (8)

Country Link
EP (1) EP3398587B1 (es)
JP (1) JP6855387B2 (es)
AU (1) AU2016381918B2 (es)
HU (1) HUE063849T2 (es)
MX (1) MX383987B (es)
PL (1) PL3398587T3 (es)
RU (1) RU2744270C2 (es)
WO (1) WO2017115745A1 (es)

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59227817A (ja) * 1983-06-07 1984-12-21 Toyo Jozo Co Ltd 持続性経口用ブレデニン製剤
JP2516408B2 (ja) * 1988-08-18 1996-07-24 エスエス製薬株式会社 被覆顆粒を含む錠剤
DE69011618T2 (de) * 1989-05-11 1994-12-15 Chugai Pharmaceutical Co Ltd Mundzubereitung zur verabreichung an bestimmter stelle des darmes.
US5540945A (en) * 1989-05-11 1996-07-30 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines
JP2879905B2 (ja) * 1989-08-28 1999-04-05 武田薬品工業株式会社 イブプロフェン含有経口投与用組成物
IT1246383B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per il mascheramento del sapore di farmaci
SE9402422D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New beads for controlled release and a pharmaceutical preparation containing the same
JP2001106639A (ja) 1999-10-04 2001-04-17 Taisho Pharmaceut Co Ltd 経口用組成物
US20040265372A1 (en) * 2003-06-27 2004-12-30 David Wynn Soft tablet containing high molecular weight cellulosics
JP2005187416A (ja) 2003-12-26 2005-07-14 Lion Corp マイクロカプセル及びその製造方法
JP4853818B2 (ja) * 2005-08-24 2012-01-11 大正製薬株式会社 イブプロフェン及び塩酸アンブロキソール含有固形製剤
CA2660374A1 (en) * 2006-08-10 2008-02-14 Cipla Limited Antiretroviral solid oral composition
WO2008052033A2 (en) * 2006-10-25 2008-05-02 Mcneil-Ppc, Inc. Ibuprofen composition
JP2008231029A (ja) * 2007-03-20 2008-10-02 Ohara Yakuhin Kogyo Kk 苦味遮蔽製剤
JP2009191034A (ja) * 2008-02-15 2009-08-27 Ss Pharmaceut Co Ltd 時限放出製剤
JP5777273B2 (ja) 2008-07-10 2015-09-09 大正製薬株式会社 不快な呈味を有する薬物を含有する製剤粒子
KR20120010228A (ko) 2009-04-09 2012-02-02 라이온 가부시키가이샤 복합체 및 그 제조 방법, 및 입상제 및 정제
MX2011011480A (es) * 2009-05-01 2012-02-28 Aptalis Pharmatech Inc Composicines de tabletas que se desintegran oralmente que comprenden combinaciones de analgesicos no opioides y opioides.
KR101683293B1 (ko) 2009-06-29 2016-12-06 라이온 가부시키가이샤 경구용 조성물
JP5549443B2 (ja) 2009-07-15 2014-07-16 ライオン株式会社 口腔内崩壊錠及びその製造方法
WO2011121824A1 (ja) * 2010-03-29 2011-10-06 アステラス製薬株式会社 口腔内崩壊錠
JP6003890B2 (ja) * 2011-06-10 2016-10-05 ニプロ株式会社 口腔内崩壊錠の製造方法
WO2014189034A1 (ja) * 2013-05-21 2014-11-27 武田薬品工業株式会社 口腔内崩壊錠
CN103860464B (zh) * 2014-03-19 2016-03-16 广州帝奇医药技术有限公司 一种抗过敏药物缓释混悬剂及其制备方法

Also Published As

Publication number Publication date
HUE063849T2 (hu) 2024-02-28
RU2018127645A (ru) 2020-01-30
RU2018127645A3 (es) 2020-04-06
EP3398587B1 (en) 2023-08-02
EP3398587C0 (en) 2023-08-02
WO2017115745A1 (ja) 2017-07-06
AU2016381918B2 (en) 2021-11-04
AU2016381918A1 (en) 2018-07-05
RU2744270C2 (ru) 2021-03-04
EP3398587A4 (en) 2019-07-31
JPWO2017115745A1 (ja) 2018-10-18
MX383987B (es) 2025-03-14
EP3398587A1 (en) 2018-11-07
PL3398587T3 (pl) 2024-01-22
BR112018013235A2 (pt) 2018-12-04
JP6855387B2 (ja) 2021-04-07

Similar Documents

Publication Publication Date Title
BR112018076601A2 (pt) formulação farmacêutica oral, métodos para tratar um paciente, e, uso de uma formulação
CL2019001686A1 (es) Composiciones de aminoácidos y métodos de tratamiento de enfermedades hepáticas.
MX2017001628A (es) Formulacion que comprende particulas.
EA201792592A1 (ru) Фармацевтические препараты, содержащие тенофовир и эмтрицитабин
CL2017002031A1 (es) Formulación en polvo nasal para el tratamiento de hipoglicemia
BR112015030140A2 (pt) forma de dosagem farmacêutica sólida para liberação de pelo menos um ingrediente farmacêutico ativo na cavidade oral
CO2017002682A2 (es) Composiciones y métodos para recubrimientos cannabinoides para uso en la entrega de fármacos
UY33076A (es) Microcápsulas de fexofenadina y composiciones que las contienen
EA201691918A1 (ru) Фармацевтические составы ингибитора киназ семейства raf, способы их получения и способы их применения
UA115811C2 (uk) Стабільний розчин об'єднаних баклофену, сорбіту і налтрексону для перорального застосування
EP3784214C0 (en) ORAL LIQUID PHARMACEUTICAL DOSAGE FORM
MX2023000187A (es) Dosificacion de vibegron para el tratamiento de vejiga sobreactiva.
EA201591568A1 (ru) Пероральная таблетированная фармацевтическая композиция двойного применения на основе сульфатных солей и способы ее применения
CY1118100T1 (el) Διαλυμα ατομοξετινης
EA201691299A1 (ru) Применение лахинимода для замедления прогрессирования болезни хантингтона
PH12016501756B1 (en) Ondansetron extended release solid dosage forms for treating either nausea, vomiting or diarrhea symptoms
EA201790622A1 (ru) Терапевтические и питательные композиции для функциональных нарушений работы пищеварительной системы
MX2018008004A (es) Preparacion farmaceutica compactada.
CO2017006985A2 (es) Producto de administración oral
EA201992844A1 (ru) Новые пероральные составы на основе белиностата
BR112018010489A8 (pt) tratamento para administração via oral, softgel, comprimido ou cápsula, método de redução dos efeitos psicoativos do thc em humanos, e solução ou tintura de lipossomos
PH12016501500B1 (en) Topical formulations of heparin
UA117416C2 (uk) Лікарський засіб у формі сиропу для орального застосування широкого спектра дії
BR112015026635A2 (pt) formulação oral com extrato de coptidis rhizome de sabor amargo mascarado
TN2019000197A1 (fr) Liquid filled hard capsule comprising effective and flexible single dose of vitamin D